Pedicure Kits Suppliers and Manufacturers

PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment

Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.

Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.

PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.

Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.

Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood. High diagnostic accuracy : Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI. Convenience : No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling Efficiency: Provides diagnosis opportunities to more people in situations where personnel and devices are limited

MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.

We have 50mil indicaid covid test kit otg usa.

Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) is used for in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs, oropharyngeal swabs and nasal swabs from individuals who are suspected of SARS-CoV-2 by their healthcare provider within the first seven days of symptom onset.

Kit Kat. Available Variants: 2 Fingers, 4 Fingers, Kit Kat Bites, Kit Kat Chunky. Packaging Configuration: 2 Fingers: 1 Box = 48 x (6 x 17 gram). 4 Fingers: 1 Box = 12 x 24 x 35 gram. Kit Kat Bites: 1 Box = 30 x 40 gram. Kit Kat Chunky: 1 Box = 6 x 24 x 38 gram. Shelf Life : 12 Months. Language in Packaging: English, Bahasa Indonesia. Port of Loading: Semarang, Indonesia. Note: We could paste sticker on each pack should there is any additional information needed (importer name, information in other language, etc)

Quick Details Pressure : High Place of Origin : Hubei, China Model Number : 20Mpa-356(7.7)mm-150L CNG Compressed Natural Gas Material : Steel, 34CrMo4 Steel Brand Name : SINOGES or OEM Branded Use : Vehicle Mother Station Transport Application : Vehicle Mother Station Transport Working pressure : 20 MPa | 200 Bar | 2901 psi Test Pressure : 37.5 MPa | 375 Bar | 5439 psi Outer Diameter : 356 mm | 14 inch Wall Thickness : 7.7 mm | 0.3 inch Water capacity : 150 L | 9154 in3 Cylinder Height : 1851 mm | 72.9 inch Cylinder Weight : 141.1 kg | 311 lb Certification : ISO 9809-1 TPED Supply Ability Supply Ability : 2646 Piece/Pieces per Week Packaging & Delivery Packaging Details : Wood Pallet Packing Port : Shanghai Picture Example : package-imgpackage-img Lead Time: Quantity(Pieces) 1 - 1 2 - 378 379 - 1134 >1134 Est. Time(days) 15 35 45 To be negotiated

3L 5L 8L10L High Pressure Oxygen Concentrator Product Description: Our oxygen concentrator adopts 220V/110V AC power supply, uses air as raw material and high-quality molecular sieve as adsorbent, and adopts the principle of pressure swing adsorption (PSA) to directly separate oxygen from nitrogen at normal temperature, oxygen of high purity is thereby produced.OLV-5A home care oxygen concentrator By supplying oxygen to patients, the machine can help the treatment of cardiovascular and cerebrovascular diseases, respiratory diseases, chronic obstructive pneumonia etc. and the rehabilitation of anoxic patients.Oxygen absorption can improve physical oxygen supply condition and achieve the purpose of oxygenating care. It is suitable for the middle-aged and elderly, people with poor physical fitness, pregnant women, students and other people who suffer different degrees of physiological hypoxia. It can also eliminate fatigue and restore somatic function after heavy physical or mental exertion. Oxygen Concentrator Product Specification Model OLV-3A OLV-5A OLV-8A OLV-10 Oxygen flow 3L/min 5L/min 8L/min 10L/min Oxygen concentration 93% ±3% Power supply 220V 22V 50Hz IHz/ll0v 15V60Hz 1Hz Output pressure 20Kpa-60Kpa Input Power 210VA 300VA 480VA 550VA Sound level Less than 45 db Net Weight 12KG 15KG 18KG 20KG Dimension(MM) 344 X 306 X 565 mm Working System Continuous flow Atomization quantity >0.15ml/min(0nly modes with atomization function

First Aid Dressing Specifications: 19mmx72mm (Fabric Based) in Carton Pack 19mmx72mm (Wash Proof) in card board carton 19mmx72mm (Non Woven) Carton 25mm Round, 19x63mm 100 Strips/Carton 38mmx38mm Fingertip Tip 100/ liter, 38mmx60mm Island Drgs. 50mmx76mm Island Drgs 60mmx110mm Strip, 25mmx76mm Description First aid dressing which is manufactured using superior quality raw material sourced from authentic vendors. These dressings are known for their effective treatment of wounds, high comfort for patients, longer shelf life, superior quality and cost-effectiveness. Our range is available in different shapes, sizes, lengths and colours. Further, the range of first-aid dressing available with us can also be customized as per specification provided by the clients.First aid dressing, first aid wound dressing consists of a high absorbent non-stick pad with elastic bandage, the non-stick pad on the outer side toward the wound has a thin membrane-like material allowing full pass of the body fluid to the absorbent layer and also make it easier to take of the dressing from the wound. This first aid dressing, first aid wound dressing is used when first treatment of middle size skin, wound and cutting injuries, it can be supplied according to customer specification.